Gyro King CNN Health News,CNN News Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials

Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials

An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.

Join Newsletter & Receive Discount Coupons!

Leave a Reply

Related Post

“Human beings had a play-based childhood from time immemorial,” says author Jonathan Haidt. What caused teen mental health decline is “between 2010 and 2015, phones, screens come sweeping in…The most

×